Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia
scientific article
Author/s
author: Wen-Chien Chou, Albert Oriol, Hagop Kantarjian, Anna Dmoszyńska, Stefan Faderl, Farhad Ravandi, Grzegorz Mazur, Agnieszka Wierzbowska, Jean-Jacques Delaunay, Mark Minden, Rena Buckstein
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.